Aug 11, 2022 / 08:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to the Processa Pharmaceuticals second-quarter 2022 earnings call. At this time, all participants have been placed on a listen-only mode, and we will open the floor for your questions and comments after the presentation.
It is now my pleasure to turn the floor over to your host, James Stanker, Chief Financial Officer of Processa Pharmaceuticals. Sir, the floor is yours.
James Stanker - Processa Pharmaceuticals, Inc. - CFO
Thank you, and welcome to Processa's second-quarter 2022 results and clinical pipeline update conference call. Joining me on the call today are our Chief Executive Officer, Dr. David Young; and our Chief Operating Officer, Mike Floyd.
Shortly before this call, we filed our June 30, 2022 Form 10-Q. I want to remind everyone that a PowerPoint presentation will accompany Dr. Young's prepared remarks. To view the PowerPoint slides, please go to the investor relations section on our website or our earnings press release and click on the webcast link to follow along.
I
Q2 2022 Processa Pharmaceuticals Inc Earnings Call Transcript
Aug 12, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers